Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule.
Maurizio ValerianiLuca MarinelliChiara ReverberiVitaliana De SanctisDavide MolloLuca NicosiaMattia Falchetto OstiPublished in: La Radiologia medica (2018)
Sixty Gy in 20 fractions is well tolerated and achieves good clinical outcomes in early primary or recurrent NSCLC patients. A greater number of patients and a longer follow-up are necessary to confirm the results obtained with our treatment.
Keyphrases
- early stage
- end stage renal disease
- newly diagnosed
- ejection fraction
- prognostic factors
- small cell lung cancer
- radiation therapy
- type diabetes
- squamous cell carcinoma
- patient reported outcomes
- adipose tissue
- high intensity
- metabolic syndrome
- lymph node
- advanced non small cell lung cancer
- epidermal growth factor receptor
- brain metastases